310 related articles for article (PubMed ID: 24071436)
41. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation.
Schulze A; Ebinger F; Rating D; Mayatepek E
Mol Genet Metab; 2001 Dec; 74(4):413-9. PubMed ID: 11749046
[TBL] [Abstract][Full Text] [Related]
42. Guanidinoacetate methyltransferase (GAMT) deficiency: late onset of movement disorder and preserved expressive language.
O'Rourke DJ; Ryan S; Salomons G; Jakobs C; Monavari A; King MD
Dev Med Child Neurol; 2009 May; 51(5):404-7. PubMed ID: 19388150
[TBL] [Abstract][Full Text] [Related]
43. Mild guanidinoacetate increase under partial guanidinoacetate methyltransferase deficiency strongly affects brain cell development.
Hanna-El-Daher L; Béard E; Henry H; Tenenbaum L; Braissant O
Neurobiol Dis; 2015 Jul; 79():14-27. PubMed ID: 25896543
[TBL] [Abstract][Full Text] [Related]
44. Primary creatine deficiency syndrome as a potential missed diagnosis in children with psychomotor delay and seizure: case presentation with two novel variants and literature review.
Rostami P; Hosseinpour S; Ashrafi MR; Alizadeh H; Garshasbi M; Tavasoli AR
Acta Neurol Belg; 2020 Jun; 120(3):511-516. PubMed ID: 31222513
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of two year treatment outcome and limited impact of arginine restriction in a patient with GAMT deficiency.
Mercimek-Mahmutoglu S; Dunbar M; Friesen A; Garret S; Hartnett C; Huh L; Sinclair G; Stockler S; Wellington S; Pouwels PJ; Salomons GS; Jakobs C
Mol Genet Metab; 2012 Jan; 105(1):155-8. PubMed ID: 22019491
[TBL] [Abstract][Full Text] [Related]
46. Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis.
Stöckler S; Marescau B; De Deyn PP; Trijbels JM; Hanefeld F
Metabolism; 1997 Oct; 46(10):1189-93. PubMed ID: 9322805
[TBL] [Abstract][Full Text] [Related]
47. Electro-clinical features and long-term outcomes in guanidinoacetate methyltransferase (GAMT) deficiency.
Yıldız Y; Ardıçlı D; Göçmen R; Yalnızoğlu D; Topçu M; Coşkun T; Tokatlı A; Haliloğlu G
Eur J Paediatr Neurol; 2024 Mar; 49():66-72. PubMed ID: 38394710
[TBL] [Abstract][Full Text] [Related]
48. Successful treatment of a guanidinoacetate methyltransferase deficient patient: findings with relevance to treatment strategy and pathophysiology.
Verbruggen KT; Sijens PE; Schulze A; Lunsing RJ; Jakobs C; Salomons GS; van Spronsen FJ
Mol Genet Metab; 2007 Jul; 91(3):294-6. PubMed ID: 17466557
[TBL] [Abstract][Full Text] [Related]
49. Creatine and creatine deficiency syndromes: biochemical and clinical aspects.
Nasrallah F; Feki M; Kaabachi N
Pediatr Neurol; 2010 Mar; 42(3):163-71. PubMed ID: 20159424
[TBL] [Abstract][Full Text] [Related]
50. Presence of guanidinoacetate may compensate creatine absence and account for less statin-induced muscle damage in GAMT-deficient compared to AGAT-deficient mice.
Balestrino M; Adriano E
Amino Acids; 2020 Apr; 52(4):667-669. PubMed ID: 32172372
[No Abstract] [Full Text] [Related]
51. Guanidinoacetate methyltransferase deficiency: differences of creatine uptake in human brain and muscle.
Ensenauer R; Thiel T; Schwab KO; Tacke U; Stöckler-Ipsiroglu S; Schulze A; Hennig J; Lehnert W
Mol Genet Metab; 2004 Jul; 82(3):208-13. PubMed ID: 15234333
[TBL] [Abstract][Full Text] [Related]
52. Stable isotope dilution microquantification of creatine metabolites in plasma, whole blood and dried blood spots for pharmacological studies in mouse models of creatine deficiency.
Tran C; Yazdanpanah M; Kyriakopoulou L; Levandovskiy V; Zahid H; Naufer A; Isbrandt D; Schulze A
Clin Chim Acta; 2014 Sep; 436():160-8. PubMed ID: 24877651
[TBL] [Abstract][Full Text] [Related]
53. Guanidinoacetate methyltransferase (GAMT) deficiency diagnosed by proton NMR spectroscopy of body fluids.
Engelke UF; Tassini M; Hayek J; de Vries M; Bilos A; Vivi A; Valensin G; Buoni S; Zannolli R; Brussel W; Kremer B; Salomons GS; Veendrick-Meekes MJ; Kluijtmans LA; Morava E; Wevers RA
NMR Biomed; 2009 Jun; 22(5):538-44. PubMed ID: 19288536
[TBL] [Abstract][Full Text] [Related]
54. Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation.
Ayanoğlu M; Korgali E; Sezer T; Aydin HI; Sönmez FM
Brain Dev; 2020 May; 42(5):418-420. PubMed ID: 32173091
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of GAMT restores GAMT activity in primary GAMT-deficient fibroblasts.
Almeida LS; Rosenberg EH; Martinez-Muñoz C; Verhoeven NM; Vilarinho L; Jakobs C; Salomons GS
Mol Genet Metab; 2006 Dec; 89(4):392-4. PubMed ID: 16899382
[TBL] [Abstract][Full Text] [Related]
56. [Diagnosis and treatment of brain creatine deficiency syndromes].
Arias-Dimas A; Vilaseca MA; Artuch R; Ribes A; Campistol J
Rev Neurol; 2006 Sep 1-15; 43(5):302-8. PubMed ID: 16941429
[TBL] [Abstract][Full Text] [Related]
57. Guanidinoacetate N-methyltransferase deficiency: Case report and brief review of the literature.
Libell JL; Lakhani DA; Balar AB; Khan M; Carpenter JS; Joseph JT
Radiol Case Rep; 2023 Dec; 18(12):4331-4337. PubMed ID: 37808418
[TBL] [Abstract][Full Text] [Related]
58. Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free L-arginine in humans.
Kayacelebi AA; Langen J; Weigt-Usinger K; Chobanyan-Jürgens K; Mariotti F; Schneider JY; Rothmann S; Frölich JC; Atzler D; Choe CU; Schwedhelm E; Huneau JF; Lücke T; Tsikas D
Amino Acids; 2015 Sep; 47(9):1893-908. PubMed ID: 26031828
[TBL] [Abstract][Full Text] [Related]
59. Creatine uptake in brain and skeletal muscle of mice lacking guanidinoacetate methyltransferase assessed by magnetic resonance spectroscopy.
Kan HE; Meeuwissen E; van Asten JJ; Veltien A; Isbrandt D; Heerschap A
J Appl Physiol (1985); 2007 Jun; 102(6):2121-7. PubMed ID: 17347380
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
